Neurelis Announces Completion of Senior Management Team Buildout to Support the Anticipated Commercial Launch of VALTOCO(TM)
Neurelis' lead product candidate for seizures, VALTOCO (diazepam nasal spray), currently under FDA review
Company's team members are all seasoned pharmaceutical industry executives with vast experience in CNS and epilepsy
SAN DIEGO, April 22, 2019 -... Biopharmaceuticals, Drug Delivery, Neurology, Personnel Neurelis, VALTOCO, diazepam, epilepsy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news